Hepatitis C Virus Vaccine: Challenges and Prospects

The hepatitis C virus (HCV) causes both acute and chronic infection and continues to be a global problem despite advances in antiviral therapeutics. Current treatments fail to prevent reinfection and remain expensive, limiting their use to developed countries, and the asymptomatic nature of acute in...

詳細記述

書誌詳細
主要な著者: Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball
フォーマット: 論文
言語:English
出版事項: MDPI AG 2020-02-01
シリーズ:Vaccines
主題:
オンライン・アクセス:https://www.mdpi.com/2076-393X/8/1/90